READING INTERNATIONAL INC Debt Disclosure
The Company’s borrowings at December 31, 2025 and 2024, net of deferred financing costs and incorporating the impact of interest rate swaps on our effective interest rates, are summarized below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of December 31, 2025 | |||||||||||||
(Dollars in thousands) |
| Maturity Date |
| Contractual |
| Balance, |
| Balance, |
| Stated |
| Effective | |||
Denominated in USD |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trust Preferred Securities (US) |
| April 30, 2027 |
| $ | 27,913 |
| $ | 27,913 |
| $ | 27,617 |
| 8.10% |
| 8.10% |
Bank of America Credit Facility (US) |
| September 18, 2026 |
|
| 6,200 |
|
| 6,200 |
|
| 6,200 |
| 10.75% |
| 10.75% |
Cinemas 1, 2, 3 Term Loan (US) |
| October 1, 2026 |
|
| 19,841 |
|
| 19,841 |
|
| 19,766 |
| 9.46% |
| 9.46% |
Minetta & Orpheum Theatres Loan (US) |
| June 1, 2026 |
|
| 6,829 |
|
| 6,829 |
|
| 6,819 |
| 7.00% |
| 7.00% |
Union Square Financing (US) (3) |
| November 6, 2026 |
|
| 49,000 |
|
| 46,641 |
|
| 46,184 |
| 10.87% |
| 10.87% |
Nationwide Theaters Corp. (US) (4) |
| September 30, 2035 |
|
| 13,648 |
|
| 13,648 |
|
| 7,648 |
| 4.75% |
| 12.66% |
Denominated in foreign currency ("FC") (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NAB Corporate Term Loan (AU) |
| July 31, 2030 |
|
| 64,019 |
|
| 64,019 |
|
| 63,732 |
| 5.25% |
| 5.25% |
|
|
|
| $ | 187,450 |
| $ | 185,091 |
| $ | 177,966 |
|
|
|
|
(1)Net of deferred financing costs amounting to $1.1 million and debt discounts (4).
(2)The contractual facilities and outstanding balances of the FC-denominated borrowings were translated into U.S. dollars based on exchange rates as of December 31, 2025.
(3)This loan has an option to extend for one year, which is within our control and we intend to exercise.
(4)This debt is carried net of debt discounts of $6.0 million.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of December 31, 2024 | |||||||||||||
(Dollars in thousands) |
| Maturity Date |
| Contractual |
| Balance, |
| Balance, |
| Stated |
| Effective | |||
Denominated in USD |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trust Preferred Securities (US) |
| April 30, 2027 |
| $ | 27,913 |
| $ | 27,913 |
| $ | 27,394 |
| 8.85% |
| 8.85% |
Bank of America Credit Facility (US) |
| August 18, 2025 |
|
| 14,750 |
|
| 14,750 |
|
| 14,699 |
| 10.50% |
| 10.50% |
Cinemas 1, 2, 3 Term Loan (US) |
| April 1, 2025 |
|
| 20,682 |
|
| 20,682 |
|
| 20,594 |
| 9.57% |
| 9.57% |
Minetta & Orpheum Theatres Loan (US) |
| June 1, 2025 |
|
| 7,464 |
|
| 7,464 |
|
| 7,446 |
| 7.00% |
| 7.00% |
Union Square Financing (US) |
| May 6, 2025 |
|
| 55,000 |
|
| 47,141 |
|
| 47,049 |
| 11.78% |
| 11.78% |
Denominated in foreign currency ("FC") (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NAB Corporate Term Loan (AU) |
| July 31, 2026 |
|
| 61,850 |
|
| 61,850 |
|
| 61,740 |
| 6.12% |
| 6.12% |
NAB Bridge Facility (AU) |
| April 30, 2025 |
|
| 12,370 |
|
| 12,370 |
|
| 12,361 |
| 6.16% |
| 6.16% |
Westpac Bank Corporate (NZ) |
| March 31, 2025 |
|
| 10,543 |
|
| 10,543 |
|
| 10,543 |
| 6.95% |
| 6.95% |
Total |
|
|
| $ | 210,572 |
| $ | 202,713 |
| $ | 201,826 |
|
|
|
|
(1)Net of deferred financing costs amounting to $0.9 million.
(2)The contractual facilities and outstanding balances of the FC-denominated borrowings were translated into U.S. dollars based on exchange rates as of December 31, 2024.
Our loan arrangements are presented, net of the deferred financing costs, on the face of our consolidated balance sheet as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in thousands) |
| December 31, | ||||
Balance Sheet Caption |
| 2025 |
| 2024 | ||
Debt - current portion |
| $ | 35,999 |
| $ | 69,193 |
Debt - long-term portion |
|
| 114,350 |
|
| 105,239 |
Subordinated debt - long-term portion |
|
| 27,617 |
|
| 27,394 |
Total borrowings |
| $ | 177,966 |
| $ | 201,826 |
Debt denominated in USD
Trust Preferred Securities (“TPS”)
On February 5, 2007, we issued $51.5 million in 20-year fully subordinated notes to a trust over which we have significant influence, which in turn issued $51.5 million in securities. Of the $51.5 million, $50.0 million in TPS were issued to unrelated investors in a private placement and $1.5 million of common trust securities were issued by the trust to Reading called “Investment in Reading International Trust I” on our balance sheets. Effective May 1, 2012, the interest rate on our Trust Preferred Securities changed from a fixed rate of 9.22%, which was in effect for five years, to a variable rate of three month LIBOR plus 4.00%, which will reset each quarter through the end of the loan unless we exercise our right to re-fix the rate at the current market rate at that time. There are no principal payments due until maturity in 2027 when the notes and the trust securities are scheduled to be paid in full. We may pay off 100% of the principal amount without any penalty. The trust is essentially a pass through, and the transaction is accounted for on our books as the issuance of fully subordinated notes. The credit facility includes a number of affirmative and negative covenants designed to monitor our ability to service the debt. The most restrictive covenant of the facility requires that we must maintain a fixed charge coverage ratio at a certain level. However, on December 31, 2008, we secured a waiver of all financial covenants with respect to our TPS for a period of nine years (through December 31, 2017), in consideration of the payment of $1.6 million, consisting of an initial payment of $1.1 million, a payment of $270,000 made in December 2011, and a payment of $270,000 in December 2014. The covenant waiver expired January 1, 2018, after which a further covenant waiver was secured on October 11, 2018 for the remaining term of the loan, in consideration of payments totaling $1.6 million, consisting of an initial payment of $1.1 million paid on October 31, 2018, and a further payment made of $270,000 in October 2021 and $225,000 made in October 2025.
During the first quarter of 2009, we took advantage of the then current market illiquidity for securities such as our TPS to repurchase $22.9 million in face value of those securities through an exchange of $11.5 million worth of marketable securities purchased during the period for the express purpose of executing this exchange transaction with the third-party holder of these TPS. During the twelve months ended 2009, we amortized $106,000 of discount to interest income associated with the holding of these securities prior to their extinguishment. On April 30, 2009, we extinguished $22.9 million of these TPS, which resulted in a gain on retirement of subordinated debt (TPS) of $10.7 million net of loss on the associated write-off of deferred loan costs of $749,000 and a reduction in our Investment in Reading International Trust I from $1.5 million to $838,000.
During the year ended December 31, 2025, we paid preferred dividends on our outstanding TPS that are included in interest expense to unrelated investors of $2.4 million. We paid $2.6 million in 2024 and paid $2.5 million in 2023. At December 31, 2025 and 2024, we had preferred dividends payable on our TPS of $372,000 and $406,000, respectively. Interest payments for this loan are required every three months.
Bank of America Credit Facility
On March 27, 2024, we amended our $6.7 million Bank of America facility to, among things, (i) extend the Maturity Date to August 18, 2025, (ii) require a $275,000 principal paydown, (iii) eliminate the minimum liquidity covenant, (iv) reduce the principal amortization amounts and provide a principal holiday period, and (v) require certain paydowns on the sale of certain real estate assets. Interest is charged at 2.5% above the Bank of America Prime rate, which itself has a floor of 1.0%. Payment-in-kind interest at a rate of 0.5% commenced on January 1, 2024, and continued until December 31, 2024, increasing to 1.5% on January 1, 2025, until the facility is repaid in full. This loan is subject to mandatory prepayment out of a portion of the net proceeds realized by us in the event that we determine to sell certain specified assets. In October 2024, we amended this facility to defer the monthly principal payments required in October, November and December, to the end of 2024. All deferred payments were made as contracted. Upon the sale of our Wellington Property assets including Courtenay Central, we repaid $6.1 million of this facility on February 5, 2025. Upon the sale of our Cannon Park property, we repaid $1.5 million of this facility.
On April 3, 2025, we further amended the facility to defer certain scheduled pay downs, which were subsequently paid upon the sale of our Cannon Park property. On July 3, 2025, we extended the maturity date to May 18, 2026, and on December 29, 2025, further extended the maturity to September 18, 2026.
Cinemas 1,2,3 Term Loan
Our $20.4 million Cinemas 1,2,3 Term Loan is held by Sutton Hill Properties LLC (“SHP). On February 26, 2025, we exercised the last of our extension options on this loan, extending the maturity to October 1, 2025. The loan is with Valley National Bank, which carries
an interest rate of 5.0% above monthly , with a floor of 7.50%. On November 13, 2025, we extended the maturity of this loan to October 1, 2026.
Minetta and Orpheum Theatres Loan
Our $7.1 million loan with Santander Bank is secured by our Minetta and Orpheum Theatres. It had previously matured on June 1, 2025, required monthly principal and interest payments with a balloon payment of $7.7 million on maturity, and carried an interest rate of 7.0%. On July 18, 2025, we extended the maturity of this loan to June 1, 2026, with various paydowns throughout the year, and a final repayment upon maturity.
Union Square Financing
Our $49.0 million loan facility, executed in 2021 with Emerald Creek Capital, is secured by our 44 Union Square property and certain limited guarantees. It bears a variable interest rate of term plus 6.9% and includes provisions for a prepaid interest and property tax reserve fund. On April 23, 2024, we executed the first twelve month extension on this loan, taking the maturity to May 6, 2025.
On May 2, 2025, we extended the maturity date of this loan to November 6, 2026, with one option to extend further to May 6, 2027. The extension provided for principal payments of $500,000 on or before May 21, 2025, and on or before and February 6, 2026. This modification and a subsequent repayment reduced the facility limit from $55.0 million to $49.0 million.
Nationwide Theaters Corp.
As part of the acquisition of Sutton Hill Associates detailed at Note 21 – Related Parties, we assumed $13.6 million of notes payable to Nationwide Theaters Corp. The notes are due in full on September 30, 2035, with interest of 4.75% per annum paid on a quarterly basis. Acquired as part of the Sutton Hill Acquisition, we carry this debt at the calculated fair value of $7.6 million based on an effective interest rate of 12.66%.
Debt denominated in foreign currencies
Australian NAB Corporate Loan Facility and Bridge Loan
Prior to March 31, 2024, our Revolving Corporate Markets Loan Facility with National Australia Bank (“NAB”) matured on July 31, 2025. It consisted of (i) an AU$100.0 million Corporate Loan facility at 1.75% above BBSY, of which AU $60.0 million was revolving and AU$40.0 million was core and (ii) a Bank Guarantee Facility of AU$5.0 million at a rate of 1.9% per annum.
On April 4, 2024, we amended this facility, which then had a maturity on July 31, 2026. As part of the amendment, we obtained an additional AU$20.0 million bridge facility (the “Bridge Loan”), which was repaid on May 21, 2025. We were also required, from March 31, 2025, to make quarterly repayments of AU$1.5 million against the AU$100.0 million Corporate Loan facility, until maturity date, representing permanent reductions in that facility’s ceiling. No other changes were made. On April 2, 2025, we executed an amendment that among other things, increased the bank guarantee facility from AU$3.0 million to AU$4.0 million.
Effective June 28, 2024, we entered into an Interest Rate Hedging Agreement with NAB on AU$50.0 million of the Corporate Loan Facility with a termination date of July 31, 2026. The Interest Rate Collar transaction has a floor of 4.18% and a cap of 4.78%.
On November 12, 2025, we extended the maturity of this loan to July 31, 2030.
Debt extinguished during 2025
NAB Bridge Facility
On May 21, 2025, we repaid our AU$20.0 million NAB Bridge Facility.
New Zealand Westpac Bank Corporate Credit Facility
On January 31, 2025, we repaid our Westpac Bank Corporate Credit.
Aggregate amount of future principal debt payments
As of December 31, 2025, our aggregate amount of future principal debt payments is estimated as follows:
|
|
|
|
|
|
|
|
(Dollars in thousands) |
| Future | |
2026 |
| $ | 83,245 |
2027 |
|
| 30,847 |
2028 |
|
| 2,934 |
2029 |
|
| 2,934 |
2030 |
|
| 51,485 |
Thereafter |
|
| 13,646 |
Total future principal debt payments |
| $ | 185,091 |
The estimated amount of future principal payments in U.S. dollars is subject to change because the payments in U.S. dollars on the debt denominated in foreign currencies, which represent a significant portion of our total outstanding debt balance, will fluctuate based on the applicable foreign currency exchange rates.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 31, 2026 | Showing above |
| 2024 | Mar 31, 2025 | |
| 2023 | Mar 29, 2024 | |
| 2022 | Mar 31, 2023 | |
| 2021 | Mar 16, 2022 | |
| 2020 | Mar 31, 2021 | |
| 2019 | Mar 16, 2020 | |
| 2018 | Mar 18, 2019 | |
| 2017 | Mar 16, 2018 | |
| 2016 | Mar 13, 2017 | |
| 2015 | Apr 29, 2016 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.